The potential is growing for MDMA-assisted therapy, also known as ecstasy, to be approved for treating PTSD as more research finds success. 

Following an FDA advisory committee's determination that a common ingredient in over-the-counter cough and cold medicines is ineffective, the agency released a statement  clarifying it has not yet made a final decision on the matter. 

The Federal Trade Commission is targeting brand-name drugmakers that are improperly listing patents, which can weaken competition. 

The updated fall COVID-19 vaccines that are beginning to roll out are not booster shots. Experts say there is an important distinction between what constitutes a booster shot and these newly formulated vaccines, CBS News reported Sept. 15.

Six pharmacy benefit managers account for 96 percent of the industry's market share, and their lead is growing, according to an analysis from the American Medical Association. 

Johnson & Johnson is reinventing itself by renaming its pharmaceutical segment and changing its logo, the company said Sept. 14. 

The National Institutes of Health has awarded New York City-based Icahn School of Medicine at Mount Sinai a five-year, $13 million grant to develop new coronavirus vaccines.

CMS has named 34 prescription drugs that could have lower out-of-pocket costs for those on Medicare, potentially saving up to $618 per dose.

The University of Wisconsin-Madison's pharmacy school unveiled a new avenue that guarantees admission for high schoolers and first-year undergrads into its PharmD program. 

The California State Board of Pharmacy documented "major deficiencies" related to staff training and knowledge in 2019 at Sutter Coast Hospital's compounding pharmacy, which was recently placed on a three-year probation.